Mega Lifesciences PCL
SET:MEGA
Operating Margin
Mega Lifesciences PCL
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | Company | Market Cap |
Operating Margin |
||
---|---|---|---|---|---|
TH |
M
|
Mega Lifesciences PCL
SET:MEGA
|
26.2B THB |
22%
|
|
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
660.9B USD |
42%
|
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
3%
|
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
424B USD |
26%
|
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
203.6B CHF |
33%
|
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
182B GBP |
24%
|
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
1.5T DKK |
46%
|
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
194B CHF |
33%
|
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
211.9B USD |
38%
|
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
183.4B USD |
11%
|
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
142.5B USD |
29%
|
Mega Lifesciences PCL
Glance View
Mega Lifesciences Public Co. Ltd. engages in the manufacture, market, sale, and distribution of pharmaceutical, nutraceutical products, and consumer goods. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2013-11-19. The firm's products include complimentary medicines, over-the-counter (OTC) medicines and prescription medicines to both domestic and international markets. The company distributes products under Maxxcare brand covering prescription pharmaceutical products, OTC drugs and other consumer products. The firm also offers nutritional products, prescription pharmaceutical products and OTC drugs under Mega We Care brand. In addition, the Company operates as an original equipment manufacturer (OEM) for various products including health supplements, pharmaceutical, herbal products, vitamins and minerals, among others.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Mega Lifesciences PCL's most recent financial statements, the company has Operating Margin of 22.4%.